April 22, 2022
2 min watch
Save
VIDEO: Ocular surface disease treatment becoming essential in refractive cataract surgery
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Adam Szaronos, CEO of TearLab, discusses the intersection of ocular surface disease treatment and refractive cataract surgery.